FTT 0.00% 0.5¢ factor therapeutics limited

Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 236 Posts.
    lightbulb Created with Sketch. 92
    I am not sure that "100% healed" can be guaranteed from this announcement but it is indeed good news and we can look forward to November.  The vast majority of the data indicates we are onto a good thing.  The abandoned ECM process and Vitrogro fiasco from 2015 has meant this treatment has taken so much longer to get to this stage than it needed to if properly managed.  Whilst I have accumulated on the slide I am sorry for all those sufferers that should now be using this product had it hit the market when anticipated.  


    Hopefully we now see the positive results of the treatment and hope it gives relief many of the sufferers of venous ulcers.



 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.